These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26658730)

  • 41. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
    Vaughn DW; Green S; Kalayanarooj S; Innis BL; Nimmannitya S; Suntayakorn S; Endy TP; Raengsakulrach B; Rothman AL; Ennis FA; Nisalak A
    J Infect Dis; 2000 Jan; 181(1):2-9. PubMed ID: 10608744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.
    Chaudhury S; Gromowski GD; Ripoll DR; Khavrutskii IV; Desai V; Wallqvist A
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005395. PubMed ID: 28222130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants.
    Adimy M; Mancera PFA; Rodrigues DS; Santos FLP; Ferreira CP
    Bull Math Biol; 2020 Jan; 82(2):24. PubMed ID: 31993759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative Analyses of Historical Trends in Confirmed Dengue Illnesses Detected at Public Hospitals in Bangkok and Northern Thailand, 2002-2018.
    Kerdpanich P; Kongkiatngam S; Buddhari D; Simasathien S; Klungthong C; Rodpradit P; Thaisomboonsuk B; Wongstitwilairoong T; Hunsawong T; Anderson KB; Fernandez S; Jones AR
    Am J Trop Med Hyg; 2020 Dec; 104(3):1058-1066. PubMed ID: 33319725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of dengue virus serotypes 1, 2 and 3 in selected regions of Kenya: 2011-2014.
    Konongoi L; Ofula V; Nyunja A; Owaka S; Koka H; Makio A; Koskei E; Eyase F; Langat D; Schoepp RJ; Rossi CA; Njeru I; Coldren R; Sang R
    Virol J; 2016 Nov; 13(1):182. PubMed ID: 27814732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A dengue transmission model in Thailand considering sequential infections with all four serotypes.
    Chikaki E; Ishikawa H
    J Infect Dev Ctries; 2009 Oct; 3(9):711-22. PubMed ID: 19858573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of infection history on dengue virus infection and pathogenicity.
    Tsang TK; Ghebremariam SL; Gresh L; Gordon A; Halloran ME; Katzelnick LC; Rojas DP; Kuan G; Balmaseda A; Sugimoto J; Harris E; Longini IM; Yang Y
    Nat Commun; 2019 Mar; 10(1):1246. PubMed ID: 30886145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-Protection of Dengue Virus Infection against Congenital Zika Syndrome, Northeastern Brazil.
    Pedroso C; Fischer C; Feldmann M; Sarno M; Luz E; Moreira-Soto A; Cabral R; Netto EM; Brites C; Kümmerer BM; Drexler JF
    Emerg Infect Dis; 2019 Aug; 25(8):1485-1493. PubMed ID: 31075077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
    Budigi Y; Ong EZ; Robinson LN; Ong LC; Rowley KJ; Winnett A; Tan HC; Hobbie S; Shriver Z; Babcock GJ; Alonso S; Ooi EE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006209. PubMed ID: 29425203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
    Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
    J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered monocyte response to the dengue virus in those with varying severity of past dengue infection.
    Kamaladasa A; Gomes L; Wijesinghe A; Jeewandara C; Toh YX; Jayathilaka D; Ogg GS; Fink K; Malavige GN
    Antiviral Res; 2019 Sep; 169():104554. PubMed ID: 31288040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.
    Sangkawibha N; Rojanasuphot S; Ahandrik S; Viriyapongse S; Jatanasen S; Salitul V; Phanthumachinda B; Halstead SB
    Am J Epidemiol; 1984 Nov; 120(5):653-69. PubMed ID: 6496446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence of Dengue Virus Infection in Adults and Children in a Prospective Longitudinal Cohort in the Philippines.
    Alera MT; Srikiatkhachorn A; Velasco JM; Tac-An IA; Lago CB; Clapham HE; Fernandez S; Levy JW; Thaisomboonsuk B; Klungthong C; Macareo LR; Nisalak A; Hermann L; Villa D; Yoon IK
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004337. PubMed ID: 26845762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.
    Swanstrom JA; Nivarthi UK; Patel B; Delacruz MJ; Yount B; Widman DG; Durbin AP; Whitehead SS; De Silva AM; Baric RS
    J Infect Dis; 2019 Jun; 220(2):219-227. PubMed ID: 30895307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine.
    Yang Y; Meng Y; Halloran ME; Longini IM
    Clin Infect Dis; 2018 Jan; 66(2):178-184. PubMed ID: 29020332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective birth cohort in a hyperendemic dengue area in Northeast Brazil: methods and preliminary results.
    Braga C; Albuquerque Mde F; Cordeiro MT; Castanha PM; Ramesh A; Alexander N; Mello MJ; Marques ET; Martelli CM
    Cad Saude Publica; 2016 Jan; 32(1):. PubMed ID: 26886185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperendemic dengue transmission and identification of a locally evolved DENV-3 lineage, Papua New Guinea 2007-2010.
    Luang-Suarkia D; Mitja O; Ernst T; Bennett S; Tay A; Hays R; Smith DW; Imrie A
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006254. PubMed ID: 29494580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dengue serotype-specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, singapore.
    Yung CF; Lee KS; Thein TL; Tan LK; Gan VC; Wong JGX; Lye DC; Ng LC; Leo YS
    Am J Trop Med Hyg; 2015 May; 92(5):999-1005. PubMed ID: 25825386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analysis of serum neutralizing antibody response in patients with primary dengue virus type 1 infection].
    Hu D; Li J; Wang D; DI B; Qiu L; Wang Y; Ding X; Che X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1773-6, 1791. PubMed ID: 23268408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.